Nordic Language Pilot Expands to 49 Substances, 19 Medicines Approved
Summary
The Nordic language pilot for English-language hospital medicine packages has expanded to 49 active substances, up from 20 when launched on January 1, 2025, with 19 medicines now approved for use across two or more participating countries. NOMA reports positive response from marketing authorisation holders, with applications encouraged for eligible products. The initiative aims to strengthen supply security and availability for low-volume essential hospital products across Denmark, Finland, Iceland, Norway, and Sweden.
“When the Nordic list of active substances eligible for the pilot was launched in January 2025, it contained 20 active substances.”
About this source
GovPing monitors Norway NOMA News alt for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 3 changes logged to date.
What changed
The Nordic language pilot for English-language common Nordic medicine packages has been expanded, with the list of eligible active substances growing from 20 to 49 since the January 2025 launch. As of February 19, 2026, 19 medicines have received approval for use with English-language common Nordic packages. The scheme was also extended last autumn to allow joint Nordic packages in English to be combined with another European language for medicines approved through the centralised procedure.
Pharmaceutical companies with medicines containing eligible active substances are encouraged to apply for participation in the pilot. Healthcare providers in Norway and other Nordic countries will see more approved products become available at hospitals. The pilot remains voluntary for industry participation.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
The Nordic language pilot marks one year and continues to expand
Published:
19/02/2026
Changes
Close The pilot project for English-language common Nordic packages for selected hospital medicines is well underway, with a growing number of products being included.
On the 1st of January 2025, the Nordic countries launched a pilot project introducing English-language joint Nordic medicine packages. The aim is to strengthen supply security and availability to low volume essential hospital products across all Nordic countries.
The project is testing common Nordic packages with English text as an alternative in cases where there are challenges with the availability of medicines used in hospitals in two or more Nordic countries – Denmark, Finland, Iceland, Norway, and Sweden.
“It is safe to use packaging in English, as healthcare professionals have access to updated electronic package leaflets in Norwegian,” says Dag Jordbru, Strategic director, Regulatory affairs and better use of medicine at NOMA.
Fortynine active substances included
The pilot is progressing well, and as of February 19th, 19 medicines have been approved for use with English-language common Nordic packages in two or more of the participating countries.
“We are pleased to see the positive response from marketing authorisation holders/producers. This initiative is important to help secure access to critical hospital medicines. We look forward to seeing more of the approved products available at Norwegian hospitals,” Jordbru says.
To apply for inclusion in the pilot, the active substance of a medicine must be included in the scheme for joint Nordic packages. See the list of substances for which companies may apply. Companies with medicines that meet the criteria are encouraged to apply for inclusion in the scheme.
When the Nordic list of active substances eligible for the pilot was launched in January 2025, it contained 20 active substances. The list has now been expanded to include 49 active substances or combinations of active substances.
Encouraging companies to participate
The Nordic medicines authorities continuously monitor the market to assess whether adjustments to the pilot are needed. One example is the extension introduced last autumn, allowing joint Nordic packages in English to be combined with another European language for medicine approved through the centralised procedure.
"We encourage relevant pharmaceutical companies to apply for participation in the pilot to strengthen supply security for these medicinal products throughout the Nordics. This can simplify production and distribution and also help ensure that patients gain better access to essential medicines," says Jordbru.
Click here to see application form.
Read more about the pilot here.
See more news
Contact us
Press inquiries
Unit for communication
Strategic director, Regulatory Affairs and Better Use of Medicines
Dag R Jordbru
Did you find what you were looking for?
Describe what you did not find
0/255 characters
I confirm that I do not submit any personal information, e.g. name, telephone number or email address. Cancel
Related changes
Get daily alerts for Norway NOMA News alt
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NOMA.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when Norway NOMA News alt publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.